Roy became Chief Commercial Officer of Evestia clinical in December 2024upon its initial investment in the acquisition of EMAS Pharma. He has over 35 years’ experience in the pharmaceutical industry, serving most recently as Chief Commercial Officer with Ergomed and as a Non-Executive Director with iVigee. Roy is a highly customer-focussed leader with an ability to take a holistic approach to business. He has led commercial teams across a wide range of geographical territories focused on partnering with biotechs and large pharmaceutical companies. He is a self-motivated leader with a strong track record in driving change and a reputation for developing potential.
His previous roles include as Chief Commercial Officer with both small and mid sized CROs and as a Non-Executive Director with emerging service providers.
At Evestia Clinical, he leads all commercial activities including sales, business operations and marketing to ensure revenue growth whilst ensuring that Evestia Clinical is the partner of choice.
Partner With Us
When every decision matters, we make sure you get them right.
